Den gavnlige effekt af tenofovirdisoproxilfumarat hos tidligere behandlede og behandlingsnaive HIV- 1- inficerede voksne er blevet påvist i forsøg af 48 ugers varighed.
The effects of tenofovir disoproxil fumarate in treatment-experienced and treatment-naïve HIV-1 infected adults have been demonstrated in trials of 48 weeks duration in treatment-experienced HIV-1 infected adults.